Grown Rogue International (GRUSF) Liabilities and Shareholders Equity (2009 - 2026)

Grown Rogue International's (GRUSF) quarterly Liabilities and Shareholders Equity came in at $65.8 million in Q1 2026, up 4.95% quarter-over-quarter from $62.7 million in Q4 2025.

Grown Rogue International (GRUSF) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Grown Rogue International's Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $65.8 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity changed N/A year-over-year to $65.8 million in Q1 2026; TTM through Mar 2026 was $103981.1 billion, a 177927083.07% increase from a year earlier, with the FY2025 full-year figure at $62.7 million, changed N/A from the prior year.
  • Liabilities and Shareholders Equity improved to $65.8 million in Q1 2026 per GRUSF's latest filing, from $62.7 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $55902.5 billion in Q3 2025 and bottomed at $18.8 million in Q1 2023.
  • The 4-year median for Liabilities and Shareholders Equity is $30.3 million (2024), against an average of $11553.5 billion.
  • Biggest YoY gain for Liabilities and Shareholders Equity was 184514363.33% in 2025; the steepest drop was 170835205.82% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $21.8 million in 2023, then surged by 39.27% to $30.3 million in 2024, then soared by 107.07% to $62.7 million in 2025, then increased by 4.95% to $65.8 million in 2026.
  • Per Business Quant, the three latest GRUSF Liabilities and Shareholders Equity figures stand at $65.8 million (Q1 2026), $62.7 million (Q4 2025), and $55902.5 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn 65.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 65.84 Mn
Dec 31, 2025 62.74 Mn
Sep 30, 2025 55,902.47 Bn
Jun 30, 2025 48,078.53 Bn
Sep 30, 2024 30.30 Mn
Jun 30, 2024 28.14 Mn
Dec 31, 2023 21.75 Mn
Apr 30, 2023 19.19 Mn
Jan 31, 2023 18.78 Mn
Apr 30, 2021 8.69 Mn
Jan 31, 2021 5.71 Mn
Oct 31, 2020 3.76 Mn
Jul 31, 2020 4.03 Mn
Apr 30, 2020 3.80 Mn
Jan 31, 2020 3.17 Mn
Oct 31, 2019 2.93 Mn
Jan 31, 2019 6.52 Mn
Oct 31, 2018 5.37 Mn
Aug 31, 2018 25,236.92
May 31, 2018 11,020.06